Related Experiment Videos
Fabry disease. A case report.
Jozica Kotnik1, Franc Kotnik, Robert J Desnick
1Dermatology Service, General Hospital Slovenj Gradec, 2380 Slovenj Gradec, Slovenija. f.kotnik@siol.net
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica
|April 9, 2005
Summary
Fabry disease, a rare genetic disorder, was diagnosed in Slovenia in 1991. Early detection of this X-linked condition is crucial for effective enzyme replacement therapy.
Area of Science:
- Genetics
- Biochemistry
- Rare Diseases
Background:
- Fabry disease is an X-linked recessive lysosomal storage disorder caused by deficient alpha-galactosidase A (alpha-Gal A) activity.
- It is often under-recognized, leading to delayed diagnosis and treatment.
Observation:
- The first case in Slovenia, a 46-year-old male, presented with abdominal purpura, proteinuria, and cardiac symptoms.
- Clinical diagnosis of angiokeratoma corporis diffusa (Fabry disease) was confirmed by low leukocyte alpha-Gal A activity.
Findings:
- The patient experienced severe multi-systemic complications including cerebrovascular, coronary, and renal disease, ultimately succumbing to myocardial infarction.
- Family studies revealed other affected males and carrier females, highlighting the X-linked inheritance pattern.
Implications:
- This case underscores the diverse clinical manifestations of Fabry disease.
- It emphasizes the importance of early diagnosis for timely intervention with enzyme replacement therapy (ERT).
- ERT offers a safe and effective treatment option for managing this inherited condition.